🇺🇸 FDA
Pipeline program

CT0594CP

CT0594CP-CG6021

Unknown mab active

Quick answer

CT0594CP for Multiple Myeloma is a Unknown program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Multiple Myeloma
Phase
Unknown
Modality
mab
Status
active

Clinical trials